FindMyKOL
Clinical trialNCT01576770UnknownPhase 4Interventional

In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction?

NCT01576770 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. As of 18 Nov 2026, it has a status the registry marks as unknown. It studies Gebauer's Ethyl Chloride in Pain on Propofol IV Injection. The registry lists an enrollment of 80 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2012 and a primary completion date of 31 Oct 2012.

SponsorThe University of Texas Health Science Center, HoustonEnrollment80Pain on Propofol IV Injection
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01576770
FieldValue
Registry IDNCT01576770
StatusUnknown
PhasePhase 4
Study typeInterventional trial
Lead sponsorThe University of Texas Health Science Center, Houston
Enrollment80
Registered sites1
Countries1
ConditionsPain on Propofol IV Injection
DrugsGebauer's Ethyl Chloride
Start30 Apr 2012
Primary completion31 Oct 2012
Study completion31 Jan 2013
Last update posted12 Apr 2012

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate if the Synera Patch (lidocaine/tetracaine patch), used to numb the skin before IV placement, is effective in reducing pain associated with propofol IV administration when inducing general anesthesia, compared to Gebauer's Ethyl Chloride topical anesthetic skin refrigerant.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Samia N Khalil, M.D.

    University of Texas Health Sciences Center at Houston

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site, 1 recruiting
  • Memorial Herman Hospital

    Houston

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 site, 1 recruitingTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Gebauer's Ethyl Chloride
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT01576770

Each answer restates registry values shown on this page.

What is NCT01576770?

NCT01576770 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. It studies Gebauer's Ethyl Chloride in Pain on Propofol IV Injection.

Who leads NCT01576770?

The registry names Samia N Khalil, M.D. (principal investigator, University of Texas Health Sciences Center at Houston) as the overall official.

Where does NCT01576770 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT01576770 study?

The registered drug and biological interventions are Gebauer's Ethyl Chloride.

When is NCT01576770 expected to complete?

The registry lists a primary completion date of 31 Oct 2012 and a study completion date of 31 Jan 2013. The sponsor last updated the record on 12 Apr 2012.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.